<< Предыдущая

стр. 5
(из 6 стр.)

ОГЛАВЛЕНИЕ

Следующая >>

45. Shin, H. D., Winkler, C., Stephens, J. C. etal. Genetic restriction
Multicenter Hemophilia Cohort Study and the International
of HIV-1 pathogenesis to AIDS by promoter alleles of IL10.
Registry of Seroconverters. AIDS8: 6 (1994), 803-10.
Proc. Natl. Acad. Sci. U.S.A. 97:26 (2000), 14467-72.
29. Eyster, M. E., Gail, M. H., Ballard, J. O., Al-Mondhiry, H. &
46. Anzala, A. O., Ball, T. B., Rostron, T., O'Brien, S. J., Plummer,
Goedert, J. J. Natural history of human immunodeficiency
F. A. & Rowland-Jones, S. L. CCR2-64I allele and genotype
virus infections in hemophiliacs: effects of T-cell subsets,
association with delayed AIDS progression in African women.
platelet counts, and age. Ann. Intern. Med. 107:1 (1987), 1-6.
University of Nairobi Collaboration for HIV Research. Lancet
30. Gandhi, R. T. & Walker, B. D. Promises and pitfalls in the 351:9116(1998), 1632-3.
reconstitution of immunity in patients who have HIV-1
47. Fauci, A. S., Pantaleo, G., Stanley, S. & Weissman, D.
infection. Curr. Opin. Immunol. 14:4 (2002), 487-94.
Immunopathogenic mechanisms of HIV infection. Ann.
31. Altfeld, M., Allen, T. M., Yu, X. G. etal. HIV-1 superinfection Intern. Med. 124:7 (1996), 654-63.
despite broad CD8+ T-cell responses containing replication
48. Bush, C. E., Donovan, R. M., Markowitz, N. P., Kvale, E &
of the primary virus. Nature420:6914 (2002), 434-9.
Saravolatz, L. D. A study of HIV RNA viral load in AIDS
32. Jost, S., Bernard, M.-C., Kaiser, L. et al. A patient with HIV-1 patients with bacterial pneumonia. J. AIDS Hum. Retrovirol.
superinfection. New Engl. J. Med. 347:10 (2002), 731-6. 13:1 (1996), 23-6.
33. Carrington, M., Nelson, G. W., Martin, M. E et al. HLA and 49. Donovan, R. M., Bush, C. E., Markowitz, N. P., Baxa, D. M.
HIV-1: heterozygote advantage and B35-Cw04 disadvantage. & Saravolatz, L. D. Changes in virus load markers during
Science283: 5408 (1999), 1748-52. AIDS-associated opportunistic diseases in human immuno
34. Kaslow, R. A., Carrington, M., Apple, R. et al. Influence of deficiency virus-infected persons. J. Infect. Dis. 174:2 (1996),
combinations of human major histocompatibility complex 401-3.
genes on the course of HIV-1 infection. Nat. Med. 2:4 (1996), 50. Stein, D. S. & Drusano, G. L. Modeling of the change in CD4
405-11. lymphocyte counts in patients before and after administra
35. Goulder, E J., Brander, C., Tang, Y. et al. Evolution and tion of the human immunodeficiency virus protease inhibitor
transmission of stable CTL escape mutations in HIV infection. indinavir. Antimicrob. Agents Chemother. 41:2 (1997),
Nature 412:6844 (2001), 334-8. 449-53.
36. O'Brien, S. J., Gao, X. & Carrington, M. HLA and AIDS: 51. Whalen, C., Horsburgh, C. R., Hom, D., Lahart, C., Simberkoff,
a cautionary tale. Trends Mol. Med. 7:9 (2001), 379-81. M. & Ellner, J. Accelerated course of human immunodeficiency
virus infection after tuberculosis. Am. J. Respir. Crit. Care Med.
37. Dean, M., Carrington, M. & O'Brien, S. J. Balanced polymor
151:1(1995), 129-35.
phism selected by genetic versus infectious human disease.
Annu. Rev. Genomics Hum. Genet. 3 (2002), 263-92. 52. Staprans, S. I., Hamilton, B. L., Follansbee, S. E. etal. Activa
tion of virus replication after vaccination of HIV-1-infected
38. Dean, M., Carrington, M., Winkler, C. et al. Genetic restriction
individuals. J. Exp. Med. 182:6 (1995), 1727-37.
of HIV-1 infection and progression to AIDS by a deletion allele




Руководство по оказанию помощи ВИЧ-инфицированным детям. Под ред. С. Зайхнера и Дж. Рид
13
Естественное течение ВИЧ-инфекции у детей



53. Stanley, S., Ostrowski, M. A., Justement, J. S. et al. Effect of 69. Centers for Disease Control and Prevention. 1994 revised
immunization with a common recall antigen on viral expres classification system for human immunodeficiency virus
sion in patients infected with human immunodeficiency virus infection in children less than 13 years. MMWR 43 (1994),
type 1. NewEngl.J. Med. 334:19 (1996), 1222-30. 1-19.
54. O'Brien, W A., Grovit-Ferbas, K., Namazi, A. et al. Human 70. National Pediatric and Family HIV Resource Center and
immunodeficiency virus-type 1 replication can be increased in National Center for Infectious Diseases, Centers for Disease
peripheral blood of seropositive patients after influenza vac Control and Prevention. 1995 revised guidelines for prophy
cination. Blood86:3 (1995), 1082-9. laxis against Pneumocystis carinii pneumonia for children
infected with or perinatally exposed to human immunode
55. Fowke, K. R., D'Amico, R., Chernoff, D. N. etal. Immunologic
ficiency virus. MMWR44:RR-4 (1995), 1-11.
and virologic evaluation after influenza vaccination of HIV-1 -
infected patients. AIDS 11:8 (1997), 1013-21. 71. Frederick, T., Mascola, L., Eller,A., O'Neil, L. & Byers, B.
Progression of human immunodeficiency virus disease among
56. Yerly, S., Wunderli, W., Wyler, C. A. etal. Influenza immuniza
infants and children infected perinatally with human
tion of HIV-1-infected patients does not increase HIV-1 viral
immunodeficiency virus or through neonatal blood
load. AIDS8:10 (1994), 1503-4.
transfusion. Los Angeles County Pediatric AIDS
57. Premack, B. A. & Schall, T. J. Chemokine receptors: gate Consortium and the Los Angeles County-University of
ways to inflammation and infection. Nat. Med. 2:11 (1996), Southern California Medical Center and the University of
1174-8. Southern California School of Medicine [see comments].
58. D'Souza, M. E & Harden, V A. Chemokines and HIV-1 sec Pediatr. Infect. Dis. J. 13:12 (1994), 1091-7.
ond receptors. Confluence of two fields generates optimism 72. Jones, D. S., Byers, R. H., Bush, T. J., Oxtoby, M. J. & Rogers, M. F.
in AIDS research. Nat. Med. 2:12 (1996), 1293-300. Epidemiology of transfusion-associated acquired immuno
59. Connor, R. I., Sheridan, K. E., Ceradini, D., Choe, S. & Landau, deficiency syndrome in children in the United States, 1981
N. R. Change in coreceptor use correlates with disease progres through 1989. Pediatrics89:1 (1992), 123-7.
sion in HIV-1-infected individuals. J. Exp. Med. 185:4 (1997), 73. Auger, I., Thomas, P., DeGruttola, V. et al. Incubation periods
621-8. for pediatric AIDS patients. Nature 336 (1988), 575-7.
60. Connor, R. I., Mohri, H., Cao, Y. & Ho, D. D. Increased viral 74. Mayaux, M. J., Burgard, M., Teglas, J. R et al. Neonatal char
burden and cytopathicity correlate temporally with CD4+ acteristics in rapidly progressive perinatally acquired HIV-
T-lymphocyte decline and clinical progression in human 1 disease. The French Pediatric HIV Infection Study Group.
immunodeficiency virus type 1-infected individuals. J. Virol. J. Am. Med. Assoc. 275:8 (1996), 606-10.
67:4 (1993), 1772-7.
75. Duliege,A.M.,Messiah,A.,Blanche,S.,Tardieu,M., Griscelli,C.
61. Koot, M., van 't Wout, A. B., Kootstra, N. A., de Goede, R. E., & Spira, A. Natural history of human immunodeficiency virus
Tersmette, M. & Schuitemaker, H. Relation between changes in type 1 infection in children: prognostic value of laboratory
cellular load, evolution of viral phenotype, and the clonal com tests on the bimodal progression of the disease. Pediatr. Infect.
position of virus populations in the course of human immuno Dis. J. 11:8 (1992), 630-5.
deficiency virus type 1 infection. J. Infect. Dis. 173:2 (1996),
76. Scott, G. B., Hutto, C., Makuch, R. W. et al. Survival in children
349-54.
with perinatally acquired human immunodeficiency virus
62. Cao, Y., Qin, L., Zhang, L., Safrit, J. & Ho, D. D. Virologic type 1 infection. New Engl. J. Med. 321:26 (1989), 1791-6.
and immunologic characterization of long-term survivors of
77. Barnhart, H. X., Caldwell, M. B., Thomas, P. et al. Natural his
human immunodeficiency virus type 1 infection. New Engl. J.
tory of human immunodeficiency virus disease in perinatally
Med. 332:4 (1995), 201-8.
infected children: an analysis from the Pediatric Spectrum of
63. Deacon, N. J., Tsykin, A., Solomon, A. et al. Genomic struc Disease Project. Pediatrics97: 5 (1996), 710-16.
ture of an attenuated quasi species of HIV-1 from a blood
78. Blanche, S., Newell, M. L., Mayaux, M. J. et al. Morbidity and
transfusion donor and recipients. Science 270:5238 (1995),
mortality in European children vertically infected by HIV- 1.
988-91.
The French Pediatric HIV Infection Study Group and European
64. Iversen, A. K., Shpaer, E. G., Rodrigo, A. G. et al. Persistence Collaborative Study. J. AIDS Hum. Retrovirol. 14:5 (1997), 442-
of attenuated rev genes in a human immunodeficiency virus 50.
type 1-infected asymptomatic individual. J. Virol. 69:9 (1995),
79. Galli, L., de Martino, M., Tovo, R A. et al. Onset of clinical signs
5743-53.
in children with HIV-1 perinatal infection. Italian Register for
65. Kirchhoff, F., Easterbrook, E J., Douglas, N. et al. Sequence HIV Infection in Children. AIDS 9:5 (1995), 455-61.
variations in human immunodeficiency virus type 1 nef are
80. Pizzo, R A. Progression of human immunodeficiency virus
associated with different stages of disease.J. Virol.73:7 (1999),
infection in children is related to the interaction of the virus,
5497-508.
the immune system, and then some [editorial; comment].
66. Michael, N. L., Chang, G., d'Arcy, L. A., Tseng, C. J., Birx, Clin. Infect. Dis. 24:5 (1997), 975-6.
D. L. & Sheppard, H. W. Functional characterization of human
81. Bryson, Y. J., Luzuriaga, K., Sullivan, J. L. & Wara, D. W. Pro
immunodeficiency virus type 1 nef genes in patients with
posed definitions for in utero versus intrapartum transmission
divergent rates of disease progression. J. Virol. 69:11 (1995),
of HIV-1. New Engl. J. Med. 327:17 (1992), 1246-7.
6758-69.
82. Doyle, M., Atkins, J. T. & Rivera-Matos, I. R. Congenital
67. Neilson, J. R., John, G. C., Carr, J. K. et al. Subtypes of
cytomegalovirus infection in infants infected with human
human immunodeficiency virus type 1 and disease stage
immunodeficiency virus type 1. Pediatr. Infect. Dis. J. 15:12
among women in Nairobi, Kenya. J. Virol. 73:5 (1999), 4393-
(1996), 1102-6.
403.
83. Nigro, G., Krzysztofiak, A., Gattinara, G. C. et al. Rapid pro
68. Osmanov, S., Pattou, C., Walker, N., Schwardlander, B. &
gression of HIV disease in children with cytomegalovirus
Esparza, J. Estimated global distribution and regional spread
DNAemia. AIDS 10:10 (1996), 1127-33.
of HIV-1 genetic subtypes in the year 2000. J. AIDS 29:2
(2002), 184-90. 84. Sabin, C. A., Phillips, A. N., Lee, C. A., Janossy, G., Emery,
V. & Griffiths, R D. The effect of CMV infection on progres
sion of human immunodeficiency virus disease is a cohort of




Руководство по оказанию помощи ВИЧ-инфицированным детям. Под ред. С. Зайхнера и Дж. Рид
14 Грейс М. Алдрованди



haemophilic men followed for up to 13 years from serocon 102. Xaha, X E., Graham, S. M., Kumwenda, N. I. et al. Morbid
version. Epidemiol. Infect. 114:2 (1995), 361-72. ity among human immunodeficiency virus-1-infected and
-uninfected African children. Pediatrics 106:6 (2000), E77.
85. Pizzo, R A. & Wilfert, C. M. Markers and determinants of dis
ease progression in children with HIV infection. The Pediatric 103. Gortmaker, S. L., Hughes, M., Cervia, J. et al. Effect of com
AIDS Siena Workshop II. J. AIDS Hum. Retrovirol. 8:1 (1995), bination therapy including protease inhibitors on mortality
30-44. among children and adolescents infected with HIV-1. New
Engl. J. Med. 345:21 (2001), 1522-8.
86. Plaeger-Marshall, S., Isacescu, V., O'Rourke, S., Bertolli, J.,
Bryson, Y. J., Stiehm, E. R. T cell activation in pediatric 104. de Martino, M., Xovo, R A., Balducci, M. et al. Reduction in
AIDS pathogenesis: three-color immunophenotyping. Clin. mortality with availability of antiretroviral therapy for chil
Immunol. Immunopathol. 71:1 (1994), 19-26. dren with perinatal HIV-1 infection. Italian Register for HIV
Infection in Children and the Italian National AIDS Registry.
87. Pollack, H., Zhan, M. X., Ilmet-Moore, T., Ajuang-Simbiri,
J. Am. Med. Assoc. 284:2 (2000), 190-7.
K., Krasinski, K. & Borkowsky, W. Ontogeny of anti-human
immunodeficiency virus (HIV) antibody production in HIV- 105. Resino, S., Bellon, J. M., Sanchez-Ramon, S. et al. Impact
1-infected infants. Proc. Natl. Acad. Sci. U.S.A. 90:6 (1993), of antiretroviral protocols on dynamics of AIDS progression
2340-4. markers. Arch. Dis. Child. 86:2 (2002), 119-24.
88. Kourtis, A. P., Ibegbu, C., Nahmias, A. J. etal. Early progression 106. Mocroft, A., Vella, S., Benfield, X L. etal. Changing patterns
of disease in HIV-infected infants with thymus dysfunction. of mortality across Europe in patients infected with HIV-1.
New Engl. J. Med. 335:19 (1996), 1431-6. EuroSIDA Study Group. Lancet 352:9142 (1998), 1725-30.
89. Dickover, R. E., Dillon, M., Gillette, S. G. etal. Rapid increases 107. Detels, R., Munoz, A., McFarlane, G. et al. Effectiveness of
in load of human immunodeficiency virus correlate with early potent antiretroviral therapy on time to AIDS and death in
disease progression and loss of CD4 cells in vertically infected men with known HIV infection duration. Multicenter AIDS
infants. J. Infect. Dis. 170:5 (1994), 1279-84. Cohort Study Investigators. J. Am. Med. Assoc. 280:17 (1998),
1497-503.
90. Shearer, W. T., Quinn, T.C., LaRussa, P. etal. Viral load and dis
ease progression in infants infected with human immuno 108. Palella, F. J., Jr., Delaney, K. M., Moorman, A. C. et al. Declin
deficiency virus type 1. Women and Infants Transmission ing morbidity and mortality among patients with advanced
Study Group. New Engl. J. Med. 336:19 (1997), 1337-42. human immunodeficiency virus infection. HIV Outpatient
Study Investigators. New Engl. J. Med. 338:13 (1998), 853-
91. De Rossi, A., Masiero, S., Giaquinto, C. et al. Dynamics of
60.
viral replication in infants with vertically acquired human
immunodeficiency virus type 1 infection. J. Clin. Invest. 97:2 109. Munoz, A., Sabin, C. A. & Phillips, A. N. The incubation period
(1996), 323-30. of AIDS. Aids 11: Suppl. A (1997), S69-76.
92. McIntosh, K., Shevitz, A., Zaknun, D. et al. Age- and time- 110. Holland, C. A., Ma, Y., Moscicki, B., Durako, S. J., Levin, L. &
related changes in extracellular viralload in children vertically Wilson, C. M. Seroprevalence and risk factors of hepatitis B,
infected by human immunodeficiency virus. Pediatr. Infect. hepatitis C, andhuman cytomegalovirus among HIV-infected
Dis. J. 15:12 (1996), 1087-91. and high-risk uninfected adolescents: findings of the REACH
Study. Adolescent Medicine HIV/AIDS ResearchNetwork. Sex.
93. UNAIDS/WHO. AIDS Epidemic Update - December 2002.
Transm. Dis. 27:5 (2000), 296-303.
Geneva: UNAIDS/WHO, 2002.
111. Wilson, C. M., Ellenberg, J. H., Sawyer, M. K. etal. Serologic
94. Cohen, J. Is AIDS in Africa a distinct disease? Science 288:
response to hepatitis B vaccine in HIV infected and high-
5474 (2000), 2153-5.
risk HIV uninfected adolescents in the REACH cohort. Reach
95. Morgan, D. & Whitworth, J. The natural history of HIV-1 infec ing for Excellence in Adolescent Care and Health. J. Adolesc.
tion in Africa. Nat. Med. 7:2 (2001), 143-5. Health. 29:3 Suppl. (2001), 123-9.
96. Morgan, D., Mahe, C., Mayanja, B. & Whitworth, J. A. Progres 112. Palumbo, R E., Raskino, C., Fiscus, S. etal. Predictive value of
sion to symptomatic disease in people infected with HIV-1 in quantitative plasma HIV RNA and CD4+ lymphocyte count in
rural Uganda: prospective cohort study. Br. Med. J. 324:7331 HIV-infected infants and children. J. Am. Med. Assoc. 279:10
(2002), 193-6. (1998), 756-61.
97. Fideli, U. S., Allen, S. A., Musonda, R. et al. Virologic and 113.Mofenson, L. M., Korelitz, J., Meyer, W A., 3rd. et al. The
immunologic determinants of heterosexual transmission of relationship between serumhuman immunodeficiency virus
human immunodeficiency virus type 1 in Africa. AIDS Res. type1 (HIV-1) RNAlevel, CD4 lymphocyte percent, and long-
Hum. Retroviruses. 17:10 (2001), 901-10. term mortality risk in HIV-1-infected children. National Insti
98. Spira, R., Lepage, P., Msellati, R etal. Natural history of human tute of Child Health and Human Development Intravenous
immunodeficiency virus type 1 infection in children: a five- Immunoglobulin Clinical Trial Study Group. J. Infect. Dis.
year prospective study in Rwanda. Mother-to-Child HIV-1 175:5(1997), 1029-38.
Transmission Study Group. Pediatrics 104:5 (1999), e56. 114. Balotta, C., Vigano, A., Riva, C. etal. HIV type 1 phenotype cor
99. Bamji, M., Thea, D. M., Weedon, J. etal. Prospective study relates with the stage of infection in vertically infected chil
of human immunodeficiency virus 1-related disease among dren. AIDS Res. Hum. Retroviruses 12:13 (1996), 1247-53.
512 infants born to infected women in New York City. The 115. Spencer, L. T., Ogino, M. T., Dankner, W. M. & Spector, S. A.
NewYorkCity Perinatal HIVTransmissionCollaborative Study Clinical significance of human immunodeficiency virus type
Group. Pediatr. Infect. Dis. J. 15:10 (1996), 891-8. 1 phenotypes in infected children. J. Infect. Dis. 169:3 (1994),
100.Lepage, P., Spira, R., Kalibala, S. etal. Care of human immuno- 491-5.
deficiency virus-infected children in developing countries. 116. Ometto, L., Zanotto, C., Maccabruni, A. et al. Viral pheno
International Working Group on Mother-to-Child Transmission type and host-cell susceptibility to HIV-1 infection as risk
of HIV. Pediatr. Infect. Dis. J. 17:7 (1998), 581-6. factors for mother-to-child HIV-1 transmission. AIDS 9 : 5
101. Dabis, F., Elenga, N., Meda, N. etal. 18-Month mortality and (1995), 427-34.
perinatal exposure to zidovudine in West Africa. AIDS 15:6 117. Just, J. J., Casabona, J., Bertran, J. et al. MHC class II alleles
(2001), 771-9. associated with clinical and immunological manifestations




Руководство по оказанию помощи ВИЧ-инфицированным детям. Под ред. С. Зайхнера и Дж. Рид
15
Естественное течение ВИЧ-инфекции у детей



of HIV-1 infection among children in Catalonia, Spain. Tissue 127. McKinney, R. E., Jr. &Wilfert, C. Growth as a prognostic indica
Antigens47:4 (1996), 313-8. tor in children withhuman immunodeficiency virus infection
treated with zidovudine. AIDS Clinical Trials Group Protocol
118. Just, J. J., Abrams, E., Louie, L. G. et al. Influence of host
043 Study Group. J. Pediatr. 125:5 (1994), 728-33.
genotype on progression to acquired immunodeficiency syn
drome among children infected with human immunodefi 128. Pollack, H., Glasberg, H., Lee, E. etal. Impaired early growth of
ciency virus type 1. J. Pediatr. 127:4 (1995), 544-9. infants perinatally infected with human immunodeficiency
119. Kostrikis, L. G., Neumann, A. U., Thomson, B. et al. Apolymor- virus: correlation with viral load. J. Pediatr. 130:6 (1997),
phism in the regulatory region of the CC-chemokine receptor 915-22.
5 gene influences perinatal transmission of human immuno 129. Nielsen, K., Ammann, A., Bryson, Y. et al. A descriptive sur
deficiency virus type 1 to African-American infants. J. Virol. vey of pediatric HIV-infected long term survivors. In 3rd Con
73:12(1999), 10264-71. ference on Retroviruses and Opportunistic Infections January
120. Goedert, J. J., Kessler, C. M., Aledort, L. M. etal. A prospective 28-February 1 (1996), p. 150. [Abstract].
study of human immunodeficiency virus type 1 infection and 130. Bryson, Y. J., Pang, S., Wei, L. S., Dickover, R., Diagne, A. &
the development of AIDS in subjects with hemophilia. New Chen, I. S. Clearance of HIV infection in a perinatally infected
Engl. J. Med. 321:17 (1989), 1141-8. infant. New Engl. J. Med. 332:13 (1995), 833-8.
121. Morris, C. R., Araba-Owoyele, L., Spector, S. A. & Maldonado, 131. Newell, M. L., Dunn, D., De Maria, A. etal. Detection of virus
Y. A. Disease patterns and survival after acquired immuno in vertically exposed HIV-antibody-negative children. Lancet
deficiency syndrome diagnosis in human immunodeficiency 347:8996 (1996), 213-5.
virus-infected children. Pediatr. Infect. Dis. J. 15:4 (1996),
132. Roques, P. A., Gras, G., Parnet-Mathieu, E et al. Clearance
321-8.

<< Предыдущая

стр. 5
(из 6 стр.)

ОГЛАВЛЕНИЕ

Следующая >>